Logo image of BLBD

BLUE BIRD CORP (BLBD) Stock Fundamental Analysis

NASDAQ:BLBD - Nasdaq - US0953061068 - Common Stock - Currency: USD

40.59  +0.66 (+1.65%)

After market: 40 -0.59 (-1.45%)

Fundamental Rating

6

Taking everything into account, BLBD scores 6 out of 10 in our fundamental rating. BLBD was compared to 129 industry peers in the Machinery industry. BLBD has only an average score on both its financial health and profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on BLBD. With these ratings, BLBD could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year BLBD was profitable.
In the past year BLBD had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BLBD reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: BLBD reported negative operating cash flow in multiple years.
BLBD Yearly Net Income VS EBIT VS OCF VS FCFBLBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

With an excellent Return On Assets value of 20.20%, BLBD belongs to the best of the industry, outperforming 98.45% of the companies in the same industry.
The Return On Equity of BLBD (60.16%) is better than 98.45% of its industry peers.
BLBD's Return On Invested Capital of 30.58% is amongst the best of the industry. BLBD outperforms 98.45% of its industry peers.
Industry RankSector Rank
ROA 20.2%
ROE 60.16%
ROIC 30.58%
ROA(3y)4.43%
ROA(5y)3.41%
ROE(3y)-1048.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLBD Yearly ROA, ROE, ROICBLBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

The Profit Margin of BLBD (8.05%) is better than 62.02% of its industry peers.
BLBD's Profit Margin has improved in the last couple of years.
BLBD has a Operating Margin (10.01%) which is in line with its industry peers.
In the last couple of years the Operating Margin of BLBD has grown nicely.
With a Gross Margin value of 18.83%, BLBD is not doing good in the industry: 74.42% of the companies in the same industry are doing better.
BLBD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.01%
PM (TTM) 8.05%
GM 18.83%
OM growth 3Y121.61%
OM growth 5Y19.19%
PM growth 3YN/A
PM growth 5Y26.86%
GM growth 3Y21.73%
GM growth 5Y7.73%
BLBD Yearly Profit, Operating, Gross MarginsBLBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BLBD is creating value.
BLBD has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BLBD has been increased compared to 5 years ago.
Compared to 1 year ago, BLBD has an improved debt to assets ratio.
BLBD Yearly Shares OutstandingBLBD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BLBD Yearly Total Debt VS Total AssetsBLBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

BLBD has an Altman-Z score of 5.81. This indicates that BLBD is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 5.81, BLBD belongs to the best of the industry, outperforming 80.62% of the companies in the same industry.
BLBD has a debt to FCF ratio of 0.78. This is a very positive value and a sign of high solvency as it would only need 0.78 years to pay back of all of its debts.
BLBD has a better Debt to FCF ratio (0.78) than 89.15% of its industry peers.
A Debt/Equity ratio of 0.49 indicates that BLBD is not too dependend on debt financing.
The Debt to Equity ratio of BLBD (0.49) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 0.78
Altman-Z 5.81
ROIC/WACC2.99
WACC10.22%
BLBD Yearly LT Debt VS Equity VS FCFBLBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

2.3 Liquidity

A Current Ratio of 1.44 indicates that BLBD should not have too much problems paying its short term obligations.
With a Current ratio value of 1.44, BLBD is not doing good in the industry: 76.74% of the companies in the same industry are doing better.
BLBD has a Quick Ratio of 1.44. This is a bad value and indicates that BLBD is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of BLBD (0.73) is worse than 82.17% of its industry peers.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.73
BLBD Yearly Current Assets VS Current LiabilitesBLBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.76% over the past year.
Measured over the past years, BLBD shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.38% on average per year.
Looking at the last year, BLBD shows a quite strong growth in Revenue. The Revenue has grown by 18.92% in the last year.
Measured over the past years, BLBD shows a small growth in Revenue. The Revenue has been growing by 5.74% on average per year.
EPS 1Y (TTM)22.76%
EPS 3Y123.91%
EPS 5Y16.38%
EPS Q2Q%7.87%
Revenue 1Y (TTM)18.92%
Revenue growth 3Y25.35%
Revenue growth 5Y5.74%
Sales Q2Q%3.74%

3.2 Future

Based on estimates for the next years, BLBD will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.60% on average per year.
Based on estimates for the next years, BLBD will show a small growth in Revenue. The Revenue will grow by 5.57% on average per year.
EPS Next Y16.13%
EPS Next 2Y14.42%
EPS Next 3Y8.6%
EPS Next 5YN/A
Revenue Next Year8.94%
Revenue Next 2Y8.58%
Revenue Next 3Y5.57%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BLBD Yearly Revenue VS EstimatesBLBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
BLBD Yearly EPS VS EstimatesBLBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 3 4

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.40, the valuation of BLBD can be described as reasonable.
Based on the Price/Earnings ratio, BLBD is valued cheaper than 90.70% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 24.95, BLBD is valued rather cheaply.
With a Price/Forward Earnings ratio of 8.91, the valuation of BLBD can be described as very reasonable.
Based on the Price/Forward Earnings ratio, BLBD is valued cheaply inside the industry as 93.02% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 20.99. BLBD is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.4
Fwd PE 8.91
BLBD Price Earnings VS Forward Price EarningsBLBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

82.17% of the companies in the same industry are more expensive than BLBD, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BLBD indicates a rather cheap valuation: BLBD is cheaper than 89.92% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10.83
EV/EBITDA 8.44
BLBD Per share dataBLBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

BLBD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of BLBD may justify a higher PE ratio.
PEG (NY)0.71
PEG (5Y)0.7
EPS Next 2Y14.42%
EPS Next 3Y8.6%

0

5. Dividend

5.1 Amount

BLBD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLUE BIRD CORP

NASDAQ:BLBD (5/13/2025, 8:19:25 PM)

After market: 40 -0.59 (-1.45%)

40.59

+0.66 (+1.65%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners112.01%
Inst Owner Change0.23%
Ins Owners0.09%
Ins Owner Change8.66%
Market Cap1.30B
Analysts83.08
Price Target54.06 (33.19%)
Short Float %16.41%
Short Ratio10.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.89%
Min EPS beat(2)10.53%
Max EPS beat(2)15.25%
EPS beat(4)4
Avg EPS beat(4)44.95%
Min EPS beat(4)10.53%
Max EPS beat(4)79.91%
EPS beat(8)8
Avg EPS beat(8)80.6%
EPS beat(12)9
Avg EPS beat(12)-112.02%
EPS beat(16)10
Avg EPS beat(16)-88.76%
Revenue beat(2)1
Avg Revenue beat(2)1.84%
Min Revenue beat(2)-0.19%
Max Revenue beat(2)3.87%
Revenue beat(4)2
Avg Revenue beat(4)4.2%
Min Revenue beat(4)-0.54%
Max Revenue beat(4)13.65%
Revenue beat(8)6
Avg Revenue beat(8)6.42%
Revenue beat(12)9
Avg Revenue beat(12)8.73%
Revenue beat(16)10
Avg Revenue beat(16)4.38%
PT rev (1m)0%
PT rev (3m)-6.09%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.55%
EPS NY rev (1m)0%
EPS NY rev (3m)1.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.99%
Revenue NY rev (1m)0.55%
Revenue NY rev (3m)-1.14%
Valuation
Industry RankSector Rank
PE 11.4
Fwd PE 8.91
P/S 0.97
P/FCF 10.83
P/OCF 9.49
P/B 7.25
P/tB 11.06
EV/EBITDA 8.44
EPS(TTM)3.56
EY8.77%
EPS(NY)4.56
Fwd EY11.22%
FCF(TTM)3.75
FCFY9.23%
OCF(TTM)4.28
OCFY10.53%
SpS41.84
BVpS5.6
TBVpS3.67
PEG (NY)0.71
PEG (5Y)0.7
Profitability
Industry RankSector Rank
ROA 20.2%
ROE 60.16%
ROCE 43.96%
ROIC 30.58%
ROICexc 55.11%
ROICexgc 86.77%
OM 10.01%
PM (TTM) 8.05%
GM 18.83%
FCFM 8.96%
ROA(3y)4.43%
ROA(5y)3.41%
ROE(3y)-1048.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y220.13%
ROICexcg growth 5Y10.5%
ROICexc growth 3Y207.87%
ROICexc growth 5Y19.73%
OM growth 3Y121.61%
OM growth 5Y19.19%
PM growth 3YN/A
PM growth 5Y26.86%
GM growth 3Y21.73%
GM growth 5Y7.73%
F-Score8
Asset Turnover2.51
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 0.78
Debt/EBITDA 0.59
Cap/Depr 112.59%
Cap/Sales 1.26%
Interest Coverage 12.81
Cash Conversion 91.86%
Profit Quality 111.31%
Current Ratio 1.44
Quick Ratio 0.73
Altman-Z 5.81
F-Score8
WACC10.22%
ROIC/WACC2.99
Cap/Depr(3y)67.41%
Cap/Depr(5y)84.95%
Cap/Sales(3y)0.9%
Cap/Sales(5y)1.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.76%
EPS 3Y123.91%
EPS 5Y16.38%
EPS Q2Q%7.87%
EPS Next Y16.13%
EPS Next 2Y14.42%
EPS Next 3Y8.6%
EPS Next 5YN/A
Revenue 1Y (TTM)18.92%
Revenue growth 3Y25.35%
Revenue growth 5Y5.74%
Sales Q2Q%3.74%
Revenue Next Year8.94%
Revenue Next 2Y8.58%
Revenue Next 3Y5.57%
Revenue Next 5YN/A
EBIT growth 1Y34.93%
EBIT growth 3Y177.79%
EBIT growth 5Y26.04%
EBIT Next Year38.79%
EBIT Next 3Y15.18%
EBIT Next 5YN/A
FCF growth 1Y433.95%
FCF growth 3YN/A
FCF growth 5Y36.54%
OCF growth 1Y380.59%
OCF growth 3YN/A
OCF growth 5Y14.81%